spacer
home > white papers > Case Study: Emerade® Auto-Injector - SHL Group
WHITE PAPERS
logo_SHL_Groupl.jpg

SHL Group

phone +886 3 217 0303
email info@shl-group.com
web http://www.shl-group.com/
email No.136 Kuo Sheng 2nd Street, Taoyuan, Taiwan 330

Case Study: Emerade® Auto-Injector


spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Mironid Announces Closing of £4.3 million ($6.2 million) Series A Financing

Cell signalling in drug development company today announced the closure of its Series A funding round
More info >>


White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>


Industry Events

14th World Advanced Therapies & Regenerative Medicine Congress 2018

16-18 May 2018, Business Design Centre, London, United Kingdom

In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products).
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement